DTC supplement brand Perelel has raised $4.7M in seed funding from Unilever Ventures, the venture arm of consumer packaged goods conglomerate Unilever, led the seed round with participation from Willow Growth Partners; M13 co-founder Courtney Reum; Revolve chief brand officer Raissa Gerona; Bumo co-founder and CEO Joan Nyugen; Glossier CMO Ali Weiss; Jenni Kayne CEO Julia Hunter; What’s Gaby Cooking founder Gaby Dalkin;…
Female pubic hair loss is a topic that often goes unaddressed and misunderstood. Many women experience hair loss in various areas of their bodies, including the pubic region, but are hesitant to discuss it openly. In this comprehensive guide, we will delve into the causes, treatment options, and prevention strategies for female pubic hair loss. Whether you’re experiencing this issue yourself or…
Organon, the global women’s healthcare pharma company, and Daré Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO (clindamycin phosphate vaginal gel, 2%). XACIATO is an FDA-approved medication for the treatment of bacterial vaginosis (BV) in females 12 years of age and older. XACIATO received both Qualified Infectious Disease Product (QIDP) and Fast Track designations from the…
England has its first Women’s Health Ambassador and it is Dame Lesley Regan, who is bringing with her a raft of expertise spanning a 42-year career in women’s health with particular interest in miscarriage, period problems, gynaecological surgery and menopause. She will support the implementation of the upcoming women’s health strategy, that aims to tackle the gender health gap and ensure services…
“The Future of Femtech”, an event co-organized by Goddess Gaia Ventures, a women’s health focused ventures fund, and Capital Enterprises, a UK-based startup ecosystem builder, brought together the local femtech community in London earlier this week. Among the highlights was a panel discussion, that featured Syrona Health Co-founder Anya Roy, Panakeia Co-founder Pahini Pandya, Consultant Physician in Sexual Health and HIV Medicine…
Global women’s health pharma company Organon has entered into an agreement with Shanghai Henlius Biotech, whereby Organon will license commercialization rights for biosimilar candidates referencing Perjeta (pertuzumab, HLX11) and Prolia/Xgeva (denosumab, HLX14). Organon will acquire exclusive global commercialization rights except for China; including Hong Kong, Macau and Taiwan. Pertuzumab is used for the treatment of certain patients with HER2+ breast cancer in combinations with…
Flo Health, a period and ovulation tracker is launching a new global business to business offering: Flo for Business. Offered in 20 languages across 245 countries, Flo for Business is designed to educate and empower employees when it comes to tracking their periods, fertility, and overall reproductive health. This new offering provides a comprehensive approach to women’s health, offering medically-backed scientific content…
Hims & Hers, the multi-specialty telehealth platform, is introducing Hers Wellness Essentials, six new supplements formulated specifically for women. The new line includes probiotic supplements that support women’s general health, mental wellness, gut health, digestive health and skin health, as well as a daily libido supplement. The new supplements are now available at select CVS Pharmacy locations nationwide, CVS.com, ForHers.com, and now the new Hers…
